中商官网
研究报告
微创医疗（HK0853）
| 科目\年度 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
原始货币 |
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 审计意见 |
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 报表核心指标 |
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 现金及现金等价物净增加额 |
-29731.80 | -17538.40 | -48305.90 | 74699.50 | 67555.90 | 15385.60 | -2600.30 | 3139.80 | 2786.00 | -11226.60 | 5786.20 | 9154.80 | -68268.30 |
| 经营活动现金流量净额 |
-4966.90 | -23187.30 | -34330.30 | -25753.00 | -2320.00 | 2645.10 | 8413.00 | 9718.60 | 8253.40 | 3072.00 | 1780.60 | 5775.30 | 28558.60 |
| 投资活动现金流量净额 |
-14973.00 | -37840.80 | -41275.20 | -65574.30 | -14813.30 | -7995.60 | -31467.20 | -8617.00 | -8281.10 | 2196.60 | -35395.20 | 610.40 | -80786.30 |
| 融资活动现金流量净额 |
-9791.90 | 43489.70 | 27299.60 | 166026.80 | 84689.20 | 20736.10 | 20453.90 | 2038.20 | 2813.70 | -16495.20 | 39400.80 | 2769.10 | -16040.60 |
| 现金及现金等价物期末余额 |
71299.50 | 101955.10 | 120300.70 | 175441.40 | 100207.70 | 28007.70 | 13005.40 | 16022.90 | 12369.40 | 9946.70 | 21560.20 | 15990.30 | 41314.90 |
| 经营活动现金流量净额 |
-4966.90 | -23187.30 | -34330.30 | -25753.00 | -2320.00 | 2645.10 | 8413.00 | 9718.60 | 8253.40 | 3072.00 | 1780.60 | 5775.30 | 28558.60 |
| 折旧与摊销 |
15951.20 | 15124.50 | 14134.70 | 9347.90 | 6875.30 | 6117.70 | 4237.60 | 3456.80 | 3608.10 | 3760.30 | 3763.50 | 713.40 | 4205.50 |
| 营运资金变动 |
-8597.30 | -3437.10 | -6932.40 | -6741.40 | 4281.90 | -5255.00 | -1076.50 | 1630.00 | 180.70 | -2174.10 | 918.10 | 1995.30 | -9379.00 |
| 投资活动现金流量净额 |
-14973.00 | -37840.80 | -41275.20 | -65574.30 | -14813.30 | -7995.60 | -31467.20 | -8617.00 | -8281.10 | 2196.60 | -35395.20 | 610.40 | -80786.30 |
| 资本性支出 |
10843.30 | 19912.10 | 25727.40 | 24792.30 | 12038.00 | 11509.20 | 9010.00 | 7817.00 | 6568.70 | 4700.20 | 6205.00 | 5175.30 | 34231.20 |
| 投资购买 |
-72369.70 | -29864.80 | -41537.60 | -22995.40 | -35500.90 | -3150.80 | -- | -300.00 | -200.00 | -- | -- | -- | -- |
| 融资活动现金流量净额 |
-9791.90 | 43489.70 | 27299.60 | 166026.80 | 84689.20 | 20736.10 | 20453.90 | 2038.20 | 2813.70 | -16495.20 | 39400.80 | 2769.10 | -16040.60 |
| 股份回购 |
-3962.60 | -119.20 | -2320.30 | -4526.00 | -349.60 | -1763.20 | -623.70 | -961.70 | -577.40 | -244.10 | -325.20 | -491.30 | -7955.40 |
| 支付股息 |
-4383.20 | -1254.40 | -1208.50 | -1187.60 | -1020.70 | -470.70 | -801.00 | -229.50 | -99.50 | -- | -- | -1461.50 | -8128.50 |
| 股票发行 |
520.50 | 585.00 | 537.60 | 14273.50 | 38565.60 | 4685.40 | 295.40 | 547.80 | 288.60 | 135.30 | 358.30 | 108.00 | 362.60 |
| 现金及现金等价物净增加额 |
-29731.80 | -17538.40 | -48305.90 | 74699.50 | 67555.90 | 15385.60 | -2600.30 | 3139.80 | 2786.00 | -11226.60 | 5786.20 | 9154.80 | -68268.30 |
| 加：现金及现金等价物期初余额 |
101955.10 | 120300.70 | 175441.40 | 100207.70 | 28007.70 | 13005.40 | 16022.90 | 12369.40 | 9946.70 | 21560.20 | 15990.30 | 6573.00 | 109520.90 |
| 汇率变动对现金及现金等价物的影响 |
-923.80 | -807.20 | -6834.80 | 534.20 | 4644.10 | -383.30 | -417.20 | 513.70 | -363.30 | -386.90 | -216.30 | 262.50 | 62.30 |
| 现金及现金等价物期末余额 |
71299.50 | 101955.10 | 120300.70 | 175441.40 | 100207.70 | 28007.70 | 13005.40 | 16022.90 | 12369.40 | 9946.70 | 21560.20 | 15990.30 | 41314.90 |